We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Review · June 11, 2020

Ranibizumab Port Delivery System in the Treatment of Age-Related Macular Degeneration

Clinical Ophthalmology (Auckland, N.Z.)

 

Additional Info

Clinical Ophthalmology (Auckland, N.Z.)
Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date
Clin Ophthalmol 2020 May 19;2020(14)1349-1355, ER Chen, PK Kaiser

Further Reading